Intravitreal Bevacizumab for the Treatment of Refractory Diabetic Macular Edema
Authors:
- 1 May 2010
- journal article
- research article
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 41 (3) , 1-7
Abstract
BACKGROUND AND OBJECTIVE: To report the effect of intravitreal bevacizumab on visual acuity and central retinal thickness (CRT) in refractory diabetic macular edema. PATIENTS AND METHODS: Records of 60 eyes of 54 consecutive patients who underwent intravitreal bevacizumab therapy for refractory diabetic macular edema were reviewed. All eyes received intravitreal bevacizumab 1.25 mg/0.05 mL, and 36 eyes underwent pretreatment and post-treatment optical coherence tomography. Mean follow-up was 7.4 months. RESULTS: Pretreatment mean visual acuity plus or minus standard deviation was 0.71 ± 0.28 logarithm of the minimum angle of resolution (LogMAR) Snellen letters. At final follow-up, mean visual acuity had improved to 0.66 ± 0.30 LogMAR ( P = .0543). Mean baseline CRT was 440 ± 106 µm, and follow-up mean CRT was 386 ± 129 µm ( P = .008). Vitrectomized eyes had worse visual acuity and CRT outcomes ( P = .002 and P = .028, respectively) compared with nonvitrectomized eyes. CONCLUSION: Intravitreal bevacizumab may provide a functional and anatomic benefit in eyes with persistent diabetic macular edema despite previous treatments. [Ophthalmic Surg Lasers Imaging 2010;41:323–329.]Keywords
This publication has 21 references indexed in Scilit:
- Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2006
- Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic RetinopathyOphthalmology, 2006
- The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic RetinopathyDiabetes, 2005
- Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edemaAmerican Journal of Ophthalmology, 2005
- Posterior subtenon triamcinolone acetonide for refractory diabetic macular edemaAmerican Journal of Ophthalmology, 2005
- Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloidGraefe's Archive for Clinical and Experimental Ophthalmology, 2004
- Intravitreal triamcinolone for refractory diabetic macular edemaOphthalmology, 2002
- The Role of Vascular Endothelial Growth Factor in AngiogenesisActa Haematologica, 2001
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Photocoagulation for Diabetic Macular EdemaArchives of Ophthalmology (1950), 1985